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Abstract
Pericytes have been suggested to play a role in regulation of vessel stability; one mechanism for this stabilization may be via
pericyte-derived vascular endothelial growth factor (VEGF). To test the hypothesis that differentiation of mesenchymal cells to pericytes/
smooth muscle cells (SMC) is accompanied by VEGF expression, we used endothelial cell (EC) and mesenchymal cell cocultures to model
cell–cell interactions that occur during vessel development. Coculture of EC and 10T1/2 cells, multipotent mesenchymal cells, led to
induction of VEGF expression by 10T1/2 cells. Increased VEGF expression was dependent on contact between EC-10T1/2 and was
mediated by transforming growth factor (TGF). A majority of VEGF produced in coculture was cell- and/or matrix-associated. Treatment
of cells with high salt, protamine, heparin, or suramin released significant VEGF, suggesting that heparan sulfate proteoglycan might be
sequestering some of the VEGF. Inhibition of VEGF in cocultures led to a 75% increase in EC apoptosis, indicating that EC survival in
cocultures is dependent on 10T1/2-derived VEGF. VEGF gene expression in developing retinal vasculature was observed in pericytes
contacting newly formed microvessels. Our observations indicate that differentiated pericytes produce VEGF that may act in a juxtacrine/
paracrine manner as a survival and/or stabilizing factor for EC in microvessels.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Vascular development is a complex process that begins
with the formation of a primary capillary plexus via angio-
genesis or vasculogenesis and ends when the primitive ves-
sels have been remodeled into quiescent, differentiated ves-
sels. Differentiated, “mature” vessels are characterized
histologically by associated pericytes/smooth muscle cells
(SMC) and a mature basement membrane. The cellular and
molecular regulation of vascular remodeling is the object of
much scrutiny, and results from in vitro and in vivo systems
have provided some insight. The angiogenesis factor, vas-
cular endothelial growth factor (VEGF), and its receptors
have been shown to be required for vessel assembly both in
vivo (Carmeliet et al., 1996; Ferrara et al., 1996) and in vitro
(Fong et al., 1999). Platelet-derived growth factor BB
(PDGF-BB), produced by immature endothelial cells (EC),
stimulates mesenchymal cell proliferation and migration
toward the EC in vitro (Hirschi et al., 1998) and the forming
vessel in vivo (Hellstro¨m et al., 1999; Lindahl et al., 1997).
Results from coculture models suggest that transforming
growth factor 1 (TGF1) that is activated upon contact
between EC and mesenchymal cells inhibits EC prolifera-
tion and migration (Antonelli-Orlidge et al., 1989; Sato et
al., 1990) and induces pericyte/SMC differentiation (Hirschi
et al., 1998; Darland and D’Amore, 2001). Whereas a num-
ber of the molecular players that mediate vessel assembly
have been identified, less is known about the cellular and
molecular control of vessel remodeling and stabilization.
* Corresponding author. Fax: 1-617-912-0128.
E-mail address: pdamore@vision.eri.harvard.edu (P.A. D’Amore).
1 Current address: Department of Cell Biology & Applied Biology
Catholic University Nijmegan Toernooiveld 1, 6525 ED Nijmeagen, The
Netherlands.
R
Available online at www.sciencedirect.com
Developmental Biology 264 (2003) 275–288 www.elsevier.com/locate/ydbio
0012-1606/$ – see front matter © 2003 Elsevier Inc. All rights reserved.
doi:10.1016/S0012-1606(03)00492-5
Pericytes have been suggested to play a role in vessel
maturation, and there is increasing evidence to indicate that
pericytes influence vessel stability. For example, there ap-
pears to be a correlation between pericyte number and
vessel stability; brain and retina, which have the highest
density of pericytes, have the lowest turnover rate
(Denekamp, 1982; Engerman et al., 1967). Pericytes have
been shown to suppress EC proliferation (Antonelli-Orlidge
et al., 1989; Hirschi et al., 1999) and migration (Sato and
Rifkin, 1989) in vitro, and the loss of pericytes in diabetic
retinopathy precedes retinal EC proliferation (Kuwabara
and Cogan, 1963; Crocker et al., 1970). In an experimental
model, retinal vessels lacking pericytes were prone to re-
gression in vivo (Benjamin et al., 1998). In addition, the
absence of pericytes in the brain microvasculature of mice
deficient in the PDGF receptor or the PDGF-BB ligand has
been correlated with EC hyperplasia (Hellstro¨m et al.,
2001), lending further credence to a role for pericytes in
suppression of EC proliferation and in stabilization of ves-
sels.
Evidence from a variety of systems suggests that imma-
ture/developing vessels are dependent on tissue-derived
VEGF. For instance, experimentally induced vessel regres-
sion in the developing murine retina can be blocked by
administration of exogenous VEGF (Alon et al., 1995).
Similarly, using a human prostate tumor cell model of
inducible VEGF expression, it was demonstrated that
VEGF loss resulted in selective EC death by apoptosis in
vessels that lacked pericytes (Benjamin et al., 1999). Thus,
we hypothesized that pericyte stabilization of vessels might
be mediated by pericyte production of VEGF. In order to
investigate whether pericyte-derived VEGF might be in-
volved in vessel stabilization, we have used a coculture
system to model the heterotypic cell–cell interactions that
occur between pericyte precursors and EC and to examine
production of VEGF. In the current study, we test the
hypothesis that the differentiation of mesenchymal cells to
pericytes/SMC is correlated with the induction of VEGF
expression, and that this VEGF is associated with EC sur-
vival and vessel stability. Our findings of VEGF production
by differentiating pericytes in two- and three-dimensional
coculture systems as well as in vivo point to a role for
pericyte-derived VEGF in vessel stabilization.
Materials and methods
Cell culture
C3H/10T1/2 mouse mesenchymal cells (10T1/2; ATCC,
Rockville, MD) and bovine aortic EC were grown in Dul-
becco’s modified Eagle’s medium (DMEM, JRH Bio-
sciences, Lenexa, KS) supplemented with 10% fetal calf
serum (FCS, Hyclone Laboratories, Logan, UT), 233.6
g/ml glutamine, 80 units/ml penicillin, 80 g/ml strepto-
mycin (GPS; Irvine Scientific, Santa Ana, CA), and 25 mM
glucose (Sigma Chemical Company, St. Louis, MO). The
homogeneity of the EC was confirmed by DiI-acetylated
LDL uptake (Biomedical Technologies, Stoughton, MA).
The cells were used under passage 20 and were maintained
at confluence for 3 days prior to use. Mouse embryo fibro-
blasts (MEF) from wild type and smad 3 null mice were
isolated as described (Piek et al., 2001) and were grown in
DMEM/10% FCS/GPS and used between passages 6 and 8.
Cell counts were determined by using a Z1 Particle Counter
(Coulter Corporation; Miami, FL).
Cocultures
Direct coculture
EC and 10T1/2 cells were plated alone or as cocultures
(1.5  105 cells/35 mm2 dish or 2.5  105 cells/well in a
6-well tissue culture dish) in DMEM/10% FCS/GPS. After
90 min, the medium was removed and replaced with serum-
free DMEM/GPS. Recombinant human TGF1 (R&D Sys-
tems, Minneapolis, MN) was added where indicated at 1
ng/ml (time course) or at 3 ng/ml (direct and Transwell
culture). These concentrations were selected on the basis of
dose response curves for stimulating 10T1/2 differentiation
to pericytes.
Transwell coculture
EC and 10T1/2 cells were cultured alone or as cocultures
(1.5  105 of each cell type) in 6-well Transwells (Corning
Inc, Corning, NY) for 72 h with or without TFG1. The EC
were plated in DMEM/10%CS/GPS at 37°C on the under-
side of the Transwells. After 90 min, the Transwells were
reinserted into the 6-well plate and 10T1/2 were plated in
the upper chamber of the Transwell. After 90 min, the cells
were washed once with serum-free medium, and 2 ml of
serum-free medium were added to each well with or without
3 ng/ml TGF1.
VEGF ELISA
Conditioned medium (CM) was removed from the Tran-
swells and 0.1% Tween 20 and protease inhibitors (2 g/ml
aprotinin, 5 g/ml leupeptin, 10 g/ml phenylmethyl sul-
fonyl fluoride, and 10 mM sodium fluoride; Sigma) were
added. The cells were gently washed with PBS and the
cell-associated material was collected into 30 l of lysis
buffer containing 20 mM Tris (pH 8.0), 150 mM NaCl, 1
mM dithiothreitol, 1% deoxycholic acid, 0.5% sodium do-
decylsulfate, 1% Nonidet P-40, and protease inhibitors (as
above). A known concentration of total protein (5–10 g)
based on a Dc protein assay (BioRad, Hercules, CA) was
assayed for each sample. CM and cell-associated material
were stored at 80°C prior to analysis and were used to
determine levels of VEGF protein using a mouse VEGF
ELISA kit that recognizes predominantly the VEGF120 and
VEGF164 isoforms of VEGFA (R&D Systems). The in-
traassay and interassay variability had coefficients of vari-
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ance of 8.2 and 8.4%, respectively, as determined by the
manufacturer for the range of protein concentrations used in
our assays. The minimum detectable concentration of
VEGF is below 3 pg/ml. The A450 for each sample was
determined relative to a VEGF dilution curve made from an
internal standard. Values from independent experiments
were compared with univariate analysis of variance
(ANOVA) and Fischer’s protected least significant differ-
ence (PLSD).
Western blot analysis
Cell-associated material (same material as was used for
ELISA assays) was separated on 10% polyacrylamide gels
and transferred to nitrocellulose filters as previously de-
scribed (Darland and D’Amore, 2001). Filters were blocked
in 5% nonfat powdered milk, 0.1% Tween 20 in PBS for 1 h
at room temperature. A polyclonal antibody to NG2 proteo-
glycan (Chemicon International, Inc., Temecula, CA) was
used at 1:1500. Filters were washed twice with alternating
0.2% Nonidet P-40 in PBS and 0.1% Tween 20 in PBS, 10
min each. The filters were incubated with the appropriate
goat anti-rabbit coupled to horseradish peroxidase and di-
luted 1:5000 (Santa Cruz, Santa Cruz, CA). Washes were
repeated as described and immunoreactive bands were vi-
sualized by using ECLPlus (Amersham) and detected on
Hyper film (Amersham). The resulting images were
scanned with Adobe Photoshop, and densitometric analysis
was conducted by using NIH Image software (National
Institutes of Health, Bethesda, MD; http://rsb.info.nih.gov/
nih-image/). Protein concentration was determined with a
Dc protein assay kit (BioRad) to ensure even loading of 8
g of total protein. NG2 band density from three indepen-
dent experiments was used to obtain the mean densitometric
units, and statistical differences were determined by using
ANOVA and Fischer’s PLSD.
Three-dimensional (3D) cultures
The 3D cocultures were established by polymerizing 200
l of Matrigel basement membrane extract (Fisher Scien-
tific, Pittsburgh, PA) in 24-well tissue culture plates. 10T1/2
and EC were labeled with PKH67 (Sigma) and PKH26
(Sigma), respectively, according to the manufacturer’s rec-
ommended protocol with modifications described previ-
ously (Darland and D’Amore, 2001). Cells were plated in
normal growth medium at a density of 2.5  104 cells of
each type per well on the Matrigel and were switched to
serum-free medium after 1 h. The prelabeled cells in 3D
cocultures were visualized by using a Dualband filter set for
FITC/TRITC (51004v2 Excitation Filter, Micro Video In-
struments, Avon, MA) on a Nikon inverted microscope.
Cocultures were established in triplicate, and photos of four
low-power fields of view were taken. Regions photographed
in each well were chosen by using an ocular grid. Collec-
tively, these fields covered approximately 18% of the total
well surface area. In order to obtain a semiquantitative
assessment of cord formation in the 3D cocultures, we
compared cord length between control and treated cultures
as previously described (Darland and D’Amore, 2001). In
brief, the slides were scanned by using Adobe Photoshop,
and each cord/structure was labeled for tracking and as-
sessed for cord length (NIH Image). All data analysis was
performed as a frequency distribution by using ANOVA
and Fischer’s PLSD. The initial assessment and quantifica-
tion were conducted by an observer masked to treatment
conditions. A subset of the analyses was repeated by an
independent observer and similar results were obtained.
Identification of cell surface- and matrix-associated
VEGF
Cocultures of EC and 10T1/2 were plated in normal
growth medium at 1  105 cells of each type/well in
12-well plates and switched to serum-free medium after 90
min. After 3 days, the CM was collected and the cells were
washed with 1 ml/well of Hank’s balanced salt solution
(HBSS, Sigma). The cells were incubated for 10 min at
37°C with 500 l/well of HBSS, 2 M NaCl, 10 mg/ml
protamine, 0.1% suramin (0.07 mM), or 100 mg/ml heparin
(Sigma). All solutions were prepared in HBSS. The eluted
material was collected and the remaining cell-associated
material was obtained by scraping and shearing in a volume
of 200 l of lysis buffer (same as that used for Western
assays). VEGF protein was quantified by ELISA assay as
described above. The total VEGF in the sample was calcu-
lated as a sum of the eluted material and the cell-associated
material and was used to determine the percentage of VEGF
in the eluted material.
Detection of apoptotic cells
EC and 10T1/2 were plated in coculture on 4-well Per-
manox Lab-Tek Chamber slides (VWR, Bridgeport, NJ) at
a total density of 3  104 cells/2cm2 well. After 90 min, the
plating medium was removed and replaced with serum-free
medium containing either 25 g/ml VEGF neutralizing an-
Table 1
Proportional distribution of VEGF protein between cell-associated (CA)




10T1/2  TGF1 42% 58%
10T1/2  EC 71% 29%
Transwell culture
10T1/2 52% 48%
10T1/2  TGF1 52% 48%
10T1/2  EC 74% 26%
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tibody or type-matched IgG as a negative control (Neomar-
kers, Fremont, CA). All conditions were plated in quadru-
plicate. The cultures were grown for 18 h, followed by
fixation in 4% paraformaldehyde in PBS. Apoptotic cells
were detected by using the DEADEnd assay kit (Promega,
Madison, WI) according to the manufacturer’s instructions.
In order to identify 10T1/2 cells in the cocultures, the cells
were immunostained for -SMA using a 1:100 dilution of
mouse anti--SMA (Dako) after DEADEnd processing.
The secondary antibody, donkey anti-mouse IgG coupled to
cy3 fluorochrome (Jackson Immunochemicals, West Grove,
PA), was used at 1:250. Antibodies were diluted in a block-
ing solution consisting of 4% donkey serum/3% bovine
serum albumin/0.1% Triton X-100 in PBS. All nuclei were
identified by labeling for 15 min at RT with 500 ng/ml
DAPI (Sigma). Sections were washed in PBS and perma-
nently mounted with ProLong Antifade reagent (Molecular
Probes, Eugene, OR). For quantification, UV fluorescence
and bright field images were obtained with a CCD camera
on a Nikon axiophot microscope. Two images were col-
lected for each of four wells to determine the percentage of
apoptotic nuclei and the cell number for a representative
1.2-mm2 area. ANOVA and Fischer’s PLSD were used to
determine significance.
VEGF in developing retinal vasculature
Eyes were isolated from P7.5 or P9.5 mice heterozygous
for the LacZ gene under control of the VEGF promoter
(Miquerol et al., 1999). The mice were from a CD-1/129
hybrid background, and the LacZ gene with a nuclear lo-
calization signal was under an independent ribosome entry
site inserted into the 3 prime untranslated region of the
VEGF gene. Whole eyes were fixed for 24 h at 4°C in 4%
paraformaldehyde and the retinas isolated. Retinas were
permeabilized and blocked in 5% donkey serum, 5% goat
serum, 0.1% saponin, 250 mM NaCl in PBS for 48 h at 4°C.
The histochemical labeling of gal activity was conducted
overnight at 4°C using the in situ gal kit (Stratagene, La
Jolla, CA).
Trypsin digests were performed essentially as described
Fig. 1. Effect of EC-10T1/2 coculture and TGF on VEGF expression. (A)
Solo and cocultures (CC) of 10T1/2 and EC were plated at 1.5  105 cells
in 35-mm2 dishes in medium containing 1% serum. The culture medium
was changed at 72 h. Cell-associated material and CM from 10T1/2 in solo
culture (gray circles), EC in solo culture (open diamonds), and 10T1/2 and
EC in CC (black squares) were collected at time points indicated and
analyzed for VEGF by ELISA. The experiment was repeated three times
with similar results and a representative experiment is shown. (B) Solo and
CC of 10T1/2 and EC were plated at 2.5  105 cells/well in 6-well tissue
culture plates in complete medium. Ninety minutes after plating, the
medium was removed and replaced with serum-free medium with or
without 3 ng/ml TGF1. Cell-associated material and CM were collected
at 3 days, and VEGF levels were determined by ELISA. The values shown
are the mean and standard deviation of five independent experiments. N.D.
is “not detectable.”
278 D.C. Darland et al. / Developmental Biology 264 (2003) 275–288
(Mizutani et al., 1996). The eye cups were incubated for 4 h
with 3% trypsin, 0.1 M Tris buffer, pH 7.8, and 0.2 M
sodium fluoride. The tissue was washed repeatedly, and the
remaining vascular web was removed by microdissection.
For immunolabeling, the antibodies used included: mouse
anti-gal (1:400 Promega), rabbit anti-NG2 (1:200; Chemi-
con, Temecula, CA), rabbit anti-GFAP (1:400; Dako,
Carpinteria, CA), and rat anti-PECAM (BD-Pharmingen,
San Diego, CA). Primary antibodies were diluted in sapo-
nin-containing blocking solution and incubated with the
tissue overnight at 4°C followed by repeated washes with
PBS. The secondary antibodies were diluted 1:200 and
included: goat anti-mouseAlexafluor 488 (Molecular
Probes), donkey anti-rabbit and anti-ratcy5 (Jackson Im-
munolabs, West Grove, PN) and donkey anti-rabbitcy3
(Jackson). In the P7.5 retinas, the EC were visualized with
B. simplicifolia isolectin coupled to FITC (Sigma) in com-
bination with NG2 or GFAP labeling. For NG2/GFAP co-
labeling, the NG2 and gal labeling were completed and the
retinas were then incubated with mouse anti-GFAP directly
coupled to cy3 (Sigma). The retinas were flat-mounted with
anti-fade reagent (Molecular Probes) and observed with an
Axiophot upright microscope (LacZ histochemistry) or with
a Leica Confocal microscope (immunofluorescence). Image
composites were generated by using Adobe Photoshop.
Results
VEGF expression in cocultures of 10T1/2 and EC
To test the hypothesis that mesenchymal cells express
VEGF as they differentiate to pericytes, we investigated
whether 10T1/2 mesenchymal cells in coculture with EC or
treated with TGF1, which induces differentiation to peri-
cytes, produce VEGF. VEGFA (hereafter referred to as
VEGF) protein in conditioned medium or in cell-associated
material was quantified by ELISA. EC cultured alone for up
to 96 h expressed negligible amounts of cell-associated (Fig.
1A, top panel) or secreted (Fig. 1A, bottom panel) VEGF.
10T1/2 cells cultured alone for 96 h produced moderate
amounts of VEGF, which was distributed equally between
CM and cell-associated material. Coculture of 10T1/2 and
EC for 96 h led to a greater than twofold increase in total
VEGF. In contrast to either cell type alone, the VEGF
produced in the cocultures remained largely cell-associated,
with less than 10% of VEGF detected in the CM. Results
were similar for cocultures grown in serum-free or in 1%
serum-containing medium (data not shown).
We have previously shown that 10T1/2 cells cocultured
with EC or treated with TGF1 differentiate into pericyte-
like cells (Darland and D’Amore, 2001; Hirschi et al.,
1998). Since the coculture of 10T1/2 and EC increased the
expression of VEGF relative to solo cultures, we wanted to
determine whether VEGF synthesis was associated with the
differentiation of 10T1/2 to pericyte-like cells. Solo cultures
of 10T1/2 or EC were cultured in the presence or absence of
3 ng/ml of TGF1 or grown in coculture for 3 days, and
VEGF levels in cell-associated material and CM were de-
termined (Fig. 1B). EC cultured alone produced negligible
levels of detectable VEGF. VEGF levels both in cocultures
and in TGF1-treated 10T1/2 cells were increased relative
to the levels produced by 10T1/2 cells alone. The amount of
VEGF in the cocultures was significantly greater than the
predicted sum of that produced by the untreated solo cul-
tures (Fig. 1B). The distribution of VEGF between soluble
and cell-associated material was approximately equal in the
Fig. 2. VEGF expression in solo and cocultures of EC and 10T1/2 cells in
Transwell. Solo and cocultures (CC) of 10T1/2 and EC were plated in com-
plete medium at a density of 1.5  105 cells/well in Transwell, with the EC
plated on the underside of the membrane and the 10T1/2 plated inside the well.
After 90 min, the cultures were switched to serum-free medium with or
without 3 ng/ml TGF1. Cell-associated material (A) and CM (B) were
collected at 3 days, and VEGF levels were determined by ELISA. The values
shown are the mean and standard deviation of five independent experiments.
N.D. is “not detectable.”
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10T1/2 solo cultures both in the presence or absence of
TGF1. In contrast, coculture of 10T1/2 with EC resulted in
marked redistribution of VEGF, with 71% of the total
VEGF cell-associated in the coculture (Table 1).
To identify the cell type producing the VEGF in the
cocultures, 10T1/2 and EC were cocultured on either side of
Transwell membranes or as solo cultures on the Transwell.
The porous membrane permits contact between the 10T1/2
and EC while allowing for separation of the two cell types
(Saunders and D’Amore, 1992). The solo cultures on the
Transwell were also treated with 3 ng/ml of TGF1. After
3 days, the cell-associated material and CM were collected
and analyzed for VEGF protein (Fig. 2). Once again, the EC
cultured alone in Transwell produced low levels of VEGF.
10T1/2 treated with TGF1 or grown in coculture with EC
produced increased amounts of VEGF compared with the
untreated solo 10T1/2 cultures. A low level of VEGF de-
tected in cell-associated material from EC in coculture was
likely due to VEGF secreted by 10T1/2 and deposited in the
matrix or on the EC surface. The distribution of VEGF
between cell-associated and CM was roughly the same
(50% for each) for the solo cultures with or without
TGF1 treatment (Table 1). However, as for the direct
coculture, associated VEGF (74%) in the Transwell cocul-
tures reflected a shift in VEGF localization with heterotypic
cell–cell contact. In summary, VEGF is induced in 10T1/2
cells in contact with EC or after treatment with TGF, and
the majority of the VEGF in the cocultures remains cell-
associated.
TGF-dependent expression of VEGF
Because there was a consistent increase in VEGF levels
in response to TGF, we wanted to determine whether
TGF was mediating the coculture-induced VEGF expres-
sion. We have previously found that TGF that is activated
in cocultures is not fully accessible to exogenously added
neutralizing reagents, such as antisera or soluble TGF
Type II receptor (Darland and D’Amore, 2001). Therefore,
to choose an approach to blocking the action of TGF1 that
would not rely on neutralization, we used mouse embryo
Fig. 3. Effect of smad 3 signal disruption on MEF differentiation and VEGF
expression. (A) MEF from wild-type and smad3/ mice were plated at 2.5
 106 cells/well in 6-well tissue culture plates in complete medium. Ninety
minutes after plating, the medium was removed and replaced with serum-free
medium with or without 3 ng/ml TGF1. (A) Cell-associated material was
collected after 3 days. Protein concentrations were determined, and 8 g
protein was separated by PAGE and transferred to nitrocellulose. The filters
were immunostained for NG2 proteoglycan and band density determined. A
representative Western blot for NG2 is shown, and the densitometric values
are the mean and standard deviation averaged from three independent exper-
iments. (B) Cell-associated material and CM were collected at 3 days and
analyzed for VEGF protein expression by ELISA for solo culture (open bars),
solo culture plus 3 ng/ml TGF1 (hatched bars), or coculture (CC, closed
bars). The values shown are the mean and standard deviation of five indepen-
dent experiments.
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fibroblasts (MEF) derived from smad3/ mice that could
not signal through the smad 3 pathway (Piek et al., 2001;
Yang et al., 1999). To assess the validity of this approach,
we determined whether MEF could respond to TGF or
coculture with EC by expression of NG2 proteoglycan; a
pericyte-associated protein (Grako and Stallcup, 1995;
Ozerdem et al., 2001; Schlingemann et al., 1990). The smad
3 null and wild-type MEF were grown alone in the presence
or absence of 3 ng/ml of TGF1 as well as in direct
coculture with EC. Western analysis revealed that coculture
or TGF treatment of MEF led to increased levels of NG2
proteoglycan (Fig. 3A). In contrast, the smad 3-deficient
MEF did not increase NG2 upon coculture with EC and
exhibited only a slight increase in NG2 with TGF treat-
ment. The increase in NG2 in response to TGF in the smad
3 null MEF is likely via the smad 2 pathway.
Since wild-type MEF respond to coculture with EC by
differentiating toward a pericyte-like fate, we analyzed
VEGF production in the cocultures (Fig. 3B). Wild-type
MEF displayed significant baseline VEGF production.
Wild-type MEF treated with TGF1 or grown in coculture
with EC had a small, but significant increase in VEGF
production. As was observed for the 10T1/2 cells, VEGF
produced by the TGF-treated wild-type MEF was equally
distributed between cell-associated and CM, whereas a ma-
jority of the VEGF in the cocultures remained cell-associ-
ated. Smad3/ MEF grown in coculture or treated with
TGF did not produce increased VEGF.
Since the smad 3 null MEF in coculture with EC were
not induced to differentiate to pericytes or to produce
VEGF, we wanted to determine whether they could form
tube-like structures in a three-dimensional angiogenesis as-
say as we have previously seen for 10T1/2 (Darland and
D’Amore, 2001). When cocultures of EC with either wild-
type or smad 3 null MEF were established in Matrigel, EC
and wild-type MEF formed cord-like structures, whereas
coculture of EC with smad 3-deficient MEF did not form
these capillary-like structures and instead formed aggre-
gates (Fig. 4A). Quantification of the structures by measur-
ing cord length (Fig. 4B) revealed distinct differences be-
tween the cocultures formed from wild type or smad 3 null
fibroblasts. Whereas the wild-type MEF and EC cocultures
had structures up to 1500 m in cord length, the majority of
the structures formed in the smad 3 null MEF-EC cocultures
were less than 400 m in length at their longest points. We
Fig. 4. Effect of smad 3 signal disruption on cord formation in 3D
cocultures of MEF and EC. Wild-type and smad 3 null (/) MEF were
prelabeled with PKH67 (green) and grown in coculture with EC prelabeled
with PKH26 (red) at a density of 2.5  104 cells/well (24-well plate) on
Matrigel. Cord formation in the wild-type fibroblasts cocultured with EC
(A, top panel) and the smad 3 null fibroblasts cocultured with EC (A, lower
panel) was visualized at 18 h. Length measurements for the coculture
structures were obtained by using NIH Image analysis, and the resulting
frequency distribution was graphed for wild-type (B, top panel) and smad
3 null fibroblasts (B, lower panel). The experiment was repeated three
times with similar results, and a representative experiment is shown.
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attempted to rescue cord formation with exogenous appli-
cation of VEGF164 and VEGF120, but we were unable to
induce cord formation in smad3/ MEF-EC cocultures
(data not shown).
VEGF localization
Because of the heparan affinity of VEGF164, the pre-
dominant coculture isoform (data not shown), we suspected
that the VEGF was bound to HSPG on the cell surface
and/or the matrix. To test this possibility, 10T1/2 and EC
grown in coculture for 3 days were treated with heparin,
NaCl, protamine, or suramin, agents all known to release
HSPG-bound proteins. The eluted VEGF protein was then
measured by ELISA and was expressed relative to the total
cell-associated VEGF (Fig. 5). All of the treatments re-
leased approximately 20% of the cell-associated VEGF.
Repeated sequential incubations or longer incubations did
not release significant amounts of additional VEGF (data
not shown). Approximately 6% of total VEGF was eluted
with the HBSS control. These results indicate that a portion
of VEGF produced in cocultures is sequestered on the cell
surface or in the matrix.
VEGF-dependent EC survival in coculture
Since the presence of pericytes is associated with vessel
stability (Benjamin et al., 1998, 1999) and VEGF supports
EC survival, we wanted to determine whether EC survival
in cocultures was mediated via a VEGF-dependent mecha-
nism. We therefore examined the effect of VEGF neutral-
ization on cell survival in direct cocultures of 10T1/2 and
EC. After 18 h, cocultures of EC and 10T1/2 in the presence
or absence of 25 g/ml VEGF neutralizing antibody were
fixed and assessed for apoptotic cells (Fig. 6). The 10T1/2
were distinguished from the EC by immunoreactivity for
-SMA. Neutralization of VEGF led to a 75% increase in
EC apoptosis, whereas the 10T1/2 cell apoptosis was unaf-
fected (Fig. 6), indicating that EC survival in coculture is
supported by 10T1/2-derived VEGF.
VEGF expression in developing retina
In order to determine the relevance of the in vitro obser-
vations to the vasculature in vivo, flat mounts of retinas
from mice heterozygous for the LacZ gene under control of
the VEGF promoter were examined (Miquerol et al., 1999).
Astrocytes have been identified previously as expressing
VEGF in the developing retina (Stone et al., 1995, 1996),
but little is known about the expression of VEGF in peri-
cytes in vivo. Therefore, we first examined the distribution
of NG2-positive pericytes compared with glial fibrillary
acidic protein (GFAP)-positive astrocytes at the front of the
developing vasculature. Labeling of retinas from postnatal
day (P) 7.5 embryos, which have immature retinal vascula-
Fig. 5. Determination of cell surface- and matrix-associated VEGF in
EC-10T1/2 cocultures. 10T1/2 and EC were plated at 1  105 cells/well in
12-well tissue culture plates in complete medium. Ninety minutes after
plating, the medium was removed and replaced with serum-free medium.
After 3 days, the CM was removed and the wells were washed once with
HBSS. Triplicate wells were incubated for 10 min at 37°C with HBSS, 2
M NaCl, 10 mg/ml protamine, 0.2% suramin, or 100 mg/ml heparin. The
eluted material and cell-associated material were collected, and VEGF
levels were determined by ELISA. The proportion of VEGF eluted is
expressed relative to the total VEGF (eluted  cell-associated) for each
condition. The experiment was repeated twice with similar results, and a
representative experiment is shown.
Fig. 6. Role of 10T1/2-derived VEGF on EC apoptosis. EC and 10T1/2
cells were plated in complete medium in 4-well LabTek chamber slides at
a total density of 3  104 cells/well. After 90 min, the cultures were
switched to serum-free medium with 25 g/ml of neutralizing VEGF
antibody (filled bars) or control mouse IgG (open bars). After 18 h, the
cells were fixed and stained by DEADEnd assay for apoptotic nuclei.
10T1/2 were distinguished from EC in coculture by immunolabeling with
-SMA, and the cell types were scored separately. The numbers shown are
the mean and standard deviation of quadruplicate samples. The experiment
was repeated three times with similar results, and a representative exper-
iment is shown.
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ture and a large avascular zone, with FITC-conjugated B.
simplicifolia showed new vessel sprouts growing into the
avascular periphery (Fig. 7A and B). Parallel retinas stained
for either NG2 or GFAP to localize pericytes and astrocytes,
respectively (Fig. 7C and D), revealed NG2-positive peri-
cyte processes extending along the newly developing vas-
culature. An overlay of the images revealed that NG2-
positive pericytes (red) are closely associated with the
newly forming vessels and, as expected, do not extend into
the avascular retina; areas of direct overlap between the EC
and pericytes appear yellow (Fig. 7E). In contrast, the over-
lay of the GFAP (red) and the corresponding lectin showed
little overlap (note lack of yellow), though the labeling
patterns are similar (Fig. 7F).
We used several approaches to confirm that pericytes in
vivo indeed express VEGF. The primary retinal vascular
plexus of P 9.5 mice is well established, but is incomplete at
the periphery. Histochemical analysis of gal activity in
retinas from P 9.5 mice heterozygous for VEGF-LacZ re-
vealed positive nuclei that were closely associated with
microvessel profiles (Fig. 8A). Retinas from P 9.5 mouse
neonates were also processed by using the trypsin digest
technique, which removes the parenchymal tissue (includ-
ing neural cells and astrocytes), leaving only the vascula-
ture–endothelial tubes with associated pericytes and smooth
muscle cells (Mizutani et al., 1996). We then immunola-
beled for gal (green) and NG2 (blue) to reveal the peri-
cytes that also expressed VEGF-LacZ (Fig. 8B). The NG2-
positive pericytes wrap around the vessel tubes, essentially
covering the microvascular tree. Trypsin-digested retinas
labeled for GFAP revealed that no astrocytes remained
associated with the vascular network (data not shown).
Confocal analysis of retinas immunolabeled for NG2
(red), gal (green), and PECAM (blue) (Fig. 8C) revealed
colocalization of gal-positive nuclei with pericytes in con-
tact with EC, with the most prominent nuclei observed at the
vessel branch points. High-power magnification showed the
NG2-positive filaments (red) around the gal-positive nu-
clei that were most closely associated with the vessels (Fig.
8C, inset). In contrast, gal-positive nuclei that were located
in the intercapillary space were NG2-negative and were
presumably astrocytes. To confirm that the cell bodies of the
VEGF-producing astrocytes were not directly associated
with the capillaries, retinal flat mounts were immunolabeled
for the astrocyte marker GFAP (red) in combination with
gal (green) and PECAM (blue) (Fig. 8D). This labeling
revealed that the nuclei of the VEGF-producing astrocytes
were situated in the intercapillary spaces from where they
extended GFAP-positive processes to contact the vascula-
ture (Fig. 8D, inset). Occasional astrocyte nuclei appeared
to be located close to a vessel; however, optical sectioning
by confocal microscopy revealed that the astrocyte nuclei
were, in fact, located in a different plane of focus and had no
direct contact with the vessel. The distinct intercapillary
localization of astrocyte nuclei was in contrast to the peri-
cyte nuclei that were directly in their characteristic position,
apposed to the vessels (Fig. 8A).
To further distinguish between VEGF-expressing peri-
cytes and astrocytes, we labeled retinas with gal (green),
NG2 (blue), and GFAP (red) (Fig. 9). An area of microvas-
culature was imaged in a series of 10 optical sections rep-
resenting a z-plane of 5 m, to confine the compressed
image to the vascular surface. NG2 labeling of pericyte
processes outlined the vessels in a pattern that is character-
istic of pericytes (Fig. 9A) (Sims, 1986). VEGF-expressing
cells, indicated by gal immunoreactivity (Fig. 9B), are
dispersed on and between the vasculature. An overlay of
NG2 and gal labeling (Fig. 9C and 9E) reveals that many
of the gal-positive nuclei are surrounded by NG2-positive
processes and are localized to capillary branch points, a
characteristic feature of pericytes in the retinal vasculature
(Kuwabara and Cogan, 1963). Immunolabeling for GFAP
revealed astrocyte processes contacting the microvascula-
ture (Fig. 9D and 9F) from somas that were out of the plane
of focus.
Discussion
During angiogenesis and vasculogenesis, the microenvi-
ronment of a nascent vessel is altered in ways that signifi-
cantly influence the progression of vessel formation. Local
modifiers of vessel formation include growth factors, extra-
cellular matrix, and neighboring cells. Pericytes and EC
interact during vessel assembly, and observations of vessel
formation in wound healing (Crocker et al., 1970) and in
retinal vascularization during development (Benjamin et al.,
1998), temporally link vessel stabilization with the presence
of pericytes. In the current study, we present data to indicate
that interaction of mesenchymal cells (pericyte precursors)
with EC leads to the induction of VEGF expression by the
pericytes in a TGF-dependent event. Further, we provide
evidence that pericytes in contact with EC in the developing
retinal vasculature in vivo express VEGF.
TGF signaling has been implicated as a mediator of
heterotypic cell–cell interactions during normal vessel for-
mation in vivo. Mice that lack TGF1 (Dickson et al., 1995)
or the cognate type II serine/threonine receptor (Oshima et
al., 1996) have defective yolk sac hematopoiesis as well as
abnormal vasculogenesis. Mice deficient in endoglin, a co-
Fig. 7. Localization of pericytes and astrocytes in developing retina. Retinas from postnatal day 7.5 mice were labeled with B. simplicifolia lectin coupled
to FITC (green) to localize the developing vasculature. Retinas were then stained for either NG2 to localize pericytes (A, C, E) or GFAP to localize astrocytes
(B, D, F). The regions shown are at the periphery of the retina, where the vascular front is extending into the avascular zone (asterisks). The arrows in (A,
C, and E) indicate NG2-positive pericytes that are apposed to the capillaries. The arrowheads in (B, D, and F) indicate astrocytes that are widely distributed.
The magnification bar is 40 m.
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receptor for TGF receptors (Barbara et al., 1999), have
defective angiogenesis with vessels that are immature and
lack normal pericyte and SMC investment (Li et al., 1999).
We have previously shown that neutralization of TGF in a
3D coculture system blocks cord formation in 10T1/2 and
EC cocultures (Darland and D’Amore, 2001). Consistent
with these data, we observed that fibroblasts unable to
transmit a TGF signal via smad 3 (smad 3/) were
unable to form cords in coculture with EC in a 3D angio-
genesis assay. While the untreated wild-type MEF have a
low basal level of NG2, they are induced to differentiate
(express more NG2 protein) and express higher levels of
VEGF in response to coculture with EC or after treatment
with TGF. Therefore, MEF provide a useful system for
testing the role of TGF in VEGF production. Taken to-
gether, our data point to a critical role for TGF in regu-
lating pericyte/EC interactions and vessel stabilization; the
mechanism of vessel stabilization is not known.
Our evidence suggests that pericyte differentiation is
locally regulated and is dependent on heterotypic cell con-
tact. The pericyte-associated proteins, SMA and NG2, are
increased in pericyte precursors in response to contact with
EC and to TGF1 treatment (Darland and D’Amore, 2001;
Hirschi et al., 1998). TGF is produced by both cell types
and is locally activated by a cell contact-dependent mech-
anism (Antonelli-Orlidge et al., 1989; Sato et al., 1990). Our
current findings suggest that 10T1/2 differentiation to peri-
cytes is correlated with VEGF production and sequestration.
This correlation may explain the vessel regression that oc-
curs in pericyte-deficient vessels in the developing vascu-
latures where regression can be prevented by the adminis-
tration of exogenous VEGF (Benjamin et al., 1998).
Pericyte expression of VEGF in vivo has not been pre-
viously examined. Using VEGF-LacZ transgenic mice, we
demonstrated VEGF expression by NG2-positive pericytes
as well as astrocytes in the developing retinal vasculature.
Taken together with our in vitro observations that the peri-
cyte-derived VEGF appears to remain cell-associated, we
suggest that contact-induced pericyte differentiation leads to
a localized source of VEGF that acts to stabilize newly
formed vessels.
The cell-associated localization of VEGF in EC-10T1/2
cocultures differed from that in TGF-treated 10T1/2 cells
alone where most of the VEGF was detected in the CM.
While the switch in localization could be due to changes
in VEGF isoform production from the more diffus-
ible VEGF120 to the heparin-binding VEGF164 or 188,
RT-PCR analysis of VEGF isoforms in Transwell cocul-
tures did not reveal a significant shift in isoform profile
(data not shown). Since a significant proportion of cell-
associated VEGF was released via interference with the
charge interactions, the cell-associated localization may be
mediated, at least in part, by VEGF association with matrix
and/or cell surface HSPG.
gal-positive astrocytes were observed interspersed
among the newly formed vasculature. These cells, whose
Fig. 8. Localization of VEGF expression in pericytes of the developing
retinal vasculature. Retinas from P9.5 VEGF-lacZ / mice were ana-
lyzed for gal activity and gal expression in combination with pericyte-
and astrocyte-associated proteins. (A) gal histochemistry showed positive
nuclei (arrows) closely associated with the microvasculature in retinal flat
mount (no counterlabeling). Phase bright red blood cells (red arrows) mark
the vessel lumen location. (B) Retinas, digested with trypsin to isolate the
vasculature free of parenchymal cells, were stained for gal (green) and
NG2 (blue) to reveal pericytes and VEGF expression (arrows). (C) Perivas-
cular nuclei positive for gal (green) were colocalized with NG2 positive
pericytes (red). The asterisk in (C) indicates an area shown in higher
magnification (inset) with gal-positive nuclei associated with NG2-posi-
tive pericyte processes (arrows). (D) GFAP-positive astrocytes (red) pri-
marily localized between vessels also expressed gal (green) (arrowheads).
The magnification bars are 40 m for (A, C, and D), 20 m for the insets,
and 8 m for (B).
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nuclei were distinctly located in the intercapillary space,
were clearly distinguishable from the pericytes whose nu-
clei were closely aligned with the vessel wall (Fig. 8).
Consistent with previous reports, we observed astrocytes in
the avascular zone preceding the vessel front (Stone et al.,
1996; Stone et al., 1995) and associated with newly formed
vessels (Fig. 7). Though the astrocytes might be considered
a source of VEGF for stabilization, the observation of Ben-
jamin et al., in which interference with the association
between pericytes and developing vessels (via inhibition of
PDGF B) led to vessel regression, indicates that the pres-
ence of the astrocytes was insufficient to prevent vessel
regression (Benjamin et al., 1998).
It is unlikely that a process as critical as vessel stability
would be mediated by a single factor. We suspect that the
production of a mature basement membrane (downstream of
TGF) as part of vessel remodeling also contributes to
vessel stabilization, perhaps coming into play at later stages
of vessel maturation. Moreover, the angiopoietins clearly
participate in vessel stabilization, though the cellular and
molecular basis for their actions are not well delineated.
Angiopoietin 1, produced by perivascular cells, blocks EC
apoptosis in HUVEC cells (Harfouche et al., 2002; Kwak et
al., 1999; Papapetropoulos et al., 1999) and stabilizes tumor
vasculature in combination with VEGF (Liu et al., 2000;
Holash et al., 1999). Recently, application of exogenous
angiopoietin 1 has been shown to lead to a partial rescue of
the abnormal retinal vessel architecture observed in the
absence of mural cells (Uemura et al., 2002); interestingly,
however, this effect was predominantly confined to larger
vessels. Angiopoietin 2 has been implicated in vessel “de-
stabilization” in several systems, including tumor vessels
(Vajkoczy et al., 2002), the pupillary membrane (Lobov et
al., 2002), and the heart (Visconti et al., 2002). Thus, it
seems clear that vessel stabilization may be governed by a
variety of factors, perhaps depending on the tissue and the
situation, be it development, maturation or pathology. Re-
gardless of the microenvironment, pericytes are likely to
contribute significantly to the integration of the vessel
growth and stabilization signals.
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